Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02778685
Brief Title: Pembrolizumab, Letrozole, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer

First Submitted : May 18, 2016
First Submitted that Met QC Criteria : May 19, 2016
First Posted : May 20, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 10, 2021
Last Update Posted : February 12, 2021